These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 33433774)
1. Death due to consumption of ibogaine: case report. Aćimović T; Atanasijević T; Denić K; Lukić V; Popović V; Bogdanović M Forensic Sci Med Pathol; 2021 Mar; 17(1):126-129. PubMed ID: 33433774 [TBL] [Abstract][Full Text] [Related]
2. Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material. Mazoyer C; Carlier J; Boucher A; Péoc'h M; Lemeur C; Gaillard Y J Forensic Sci; 2013 Nov; 58(6):1666-72. PubMed ID: 23919354 [TBL] [Abstract][Full Text] [Related]
3. Determination of ibogaine and noribogaine in biological fluids and hair by LC-MS/MS after Tabernanthe iboga abuse Iboga alkaloids distribution in a drowning death case. Chèze M; Lenoan A; Deveaux M; Pépin G Forensic Sci Int; 2008 Mar; 176(1):58-66. PubMed ID: 18024037 [TBL] [Abstract][Full Text] [Related]
4. Ibogaine related sudden death: a case report. Papadodima SA; Dona A; Evaggelakos CI; Goutas N; Athanaselis SA J Forensic Leg Med; 2013 Oct; 20(7):809-11. PubMed ID: 24112325 [TBL] [Abstract][Full Text] [Related]
7. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Mash DC; Kovera CA; Pablo J; Tyndale RF; Ervin FD; Williams IC; Singleton EG; Mayor M Ann N Y Acad Sci; 2000 Sep; 914():394-401. PubMed ID: 11085338 [TBL] [Abstract][Full Text] [Related]
12. Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation. Antonio T; Childers SR; Rothman RB; Dersch CM; King C; Kuehne M; Bornmann WG; Eshleman AJ; Janowsky A; Simon ER; Reith ME; Alper K PLoS One; 2013; 8(10):e77262. PubMed ID: 24204784 [TBL] [Abstract][Full Text] [Related]
13. Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias. Grogan J; Gerona R; Snow JW; Kao L J Emerg Med; 2019 Oct; 57(4):e99-e104. PubMed ID: 31630892 [TBL] [Abstract][Full Text] [Related]
14. Metabolic plasticity and the energy economizing effect of ibogaine, the principal alkaloid of Tabernanthe iboga. Paškulin R; Jamnik P; Danevčič T; Koželj G; Krašovec R; Krstić-Milošević D; Blagojević D; Strukelj B J Ethnopharmacol; 2012 Aug; 143(1):319-24. PubMed ID: 22751004 [TBL] [Abstract][Full Text] [Related]
15. Distribution of ibogaine and noribogaine in a man following a poisoning involving root bark of the Tabernanthe iboga shrub. Kontrimaviciūte V; Mathieu O; Mathieu-Daudé JC; Vainauskas P; Casper T; Baccino E; Bressolle FM J Anal Toxicol; 2006 Sep; 30(7):434-40. PubMed ID: 16959135 [TBL] [Abstract][Full Text] [Related]
16. Development of novel medications for drug addiction. The legacy of an African shrub. Glick SD; Maisonneuve IM Ann N Y Acad Sci; 2000; 909():88-103. PubMed ID: 10911925 [TBL] [Abstract][Full Text] [Related]
17. Metabolite Profiling of Anti-Addictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae). Krengel F; Chevalier Q; Dickinson J; Herrera Santoyo J; Reyes Chilpa R Chem Biodivers; 2019 Apr; 16(4):e1800506. PubMed ID: 30618175 [TBL] [Abstract][Full Text] [Related]
18. Ibogaine for treating drug dependence. What is a safe dose? Schep LJ; Slaughter RJ; Galea S; Newcombe D Drug Alcohol Depend; 2016 Sep; 166():1-5. PubMed ID: 27426011 [TBL] [Abstract][Full Text] [Related]
19. Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependence Mash DC; Kovera CA; Buck BE; Norenberg MD; Shapshak P; Hearn WL; Sanchez-Ramos J Ann N Y Acad Sci; 1998 May; 844(1):274-292. PubMed ID: 29090804 [TBL] [Abstract][Full Text] [Related]
20. [Ibogaine - structure, influence on human body, clinical relevance]. Zdrojewicz Z; Kuszczak B; Olszak N Pol Merkur Lekarski; 2016 Jul; 41(241):50-55. PubMed ID: 27734823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]